Corbus Pharmaceuticals will present late-breaking Phase 1B data for obesity drug candidate CRB-913 at Obesity Week. The poster is scheduled for Nov. 15, 2:30-3:

BWB News TV • 2026-11-13 16:21 UTC • By Billy Odell Tucker-Robinson

Corbus Pharmaceuticals will present late-breaking Phase 1B data for obesity drug candidate CRB-913 at Obesity Week. The poster is scheduled for Nov. 15, 2:30-3:30 p.m. ET, for a program central to the company’s obesity pipeline.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly